<DOC>
	<DOCNO>NCT02777437</DOCNO>
	<brief_summary>Primary Outcome Measures : Disease free survival Secondary Outcome Measures : Overall survival Adverse event ( Mortality , morbidity ) The proportion completion Laparoscopic Surgery Estimated Enrollment : Oct , 2016 Study Start Date : Oct , 2016 Estimated Study Completion Date : Oct , 2019 Estimated Primary Completion Date : Oct , 2021 Groups/Cohorts 1 . Laparoscopic surgery T4 colon cancer 2 . Neoadjuvantive chemotherapy + Laparoscopic surgery T4 colon cancer</brief_summary>
	<brief_title>Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy T4 Tumor Colon Cancer</brief_title>
	<detailed_description>Investigators ' previous study indicate laparoscopic surgery feasible T4 colon cancer comparable clinical oncologic outcome . Laparoscopy may consider alternative approach T4 colon cancer advantage fast recovery . The survival outcome T4 colon cancer still dismay clinicians patient . Preoperative chemotherapy attractive concept locally advanced colon cancer . Optimal systemic therapy early possible opportunity may effective eradicate distant metastasis treatment give delay immunological stress surgery . Besides , shrinkage primary tumor surgery may reduce risk incomplete surgical excision risk shed tumor cell surgery . The aim present study compare short-and long-term survival outcome laparoscopic surgery alone laparoscopic surgery 4 cycle neoadjuvant chemotherapy T4 colon cancer well mortality morbidity . The number patient , need get power 80 % , 1960 . The average number patient need reach approximately 200 , surgical center need reach 10 . Arrangements preoperative , intraoperative postoperative period complete accordance usual care center . The baseline demographic condition well perioperative item postoperative occurrence record prior design e-questionnaire . Globally , disease free survival rate ( chemotherapy surgery ) , mortality ( chemotherapy surgery ) , morbidity ( chemotherapy surgery ) proportion completion laparoscopic surgery two surgical strategy analized compare .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Able provide write informed consent Histologically confirm diagnosis colon carcinoma CT MRI verify T4 colon cancer without involvement organ . Without multiple lesion carcinoma situ Tumor size &lt; 8 cm No bowel obstruction Sufficient organ function No history gastrointestinal surgery 18 year age old Performance Status ( ECOG ) 0 , 1 2 , life expectancy &gt; 12 week Operable patient Completion neoadjuvant systemic chemotherapy Women pregnant ( confirm serum bHCG woman reproductive age ) breast feed No intention finish neoadjuvantive systemic therapy Unstable uncompensated respiratory cardiac disease Serious active infection Hypersensitivity capecitabine/fluorouracil oxaliplatin Stomatitis ulceration mouth gastrointestinal tract Severe diarrhea Peripheral sensory neuropathy functional impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Colonic Neoplasms</keyword>
	<keyword>Laparoscopic Surgery</keyword>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>T4</keyword>
</DOC>